Edition:
United Kingdom

Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

91.30PLN
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
91.30zł
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,761
52-wk High
139.00zł
52-wk Low
86.00zł

Latest Key Developments (Source: Significant Developments)

Mabion Files Second Patent Application
Friday, 26 Oct 2018 

Oct 29 (Reuters) - MABION SA ::SAID ON FRIDAY IT FILED A SECOND PATENT APPLICATION FOR ITS INVENTION FROM AREA OF ​​APPLICATION OF MABIONCD20 IN TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS 'LOW AGGREGATE ANTI CD20 LIGAND FORMULATION'.IN DEC. 2017 CO FILED FOR PATENT FOR ITS INVENTION 'COMBINATION THERAPY OF MULTIPLE SCLEROSIS COMPRISING A CD20 LIGAND' nFWN1O50T6.  Full Article

Mabion Gets USD 5 Mln Milestone Payment From Mylan Ireland
Monday, 27 Aug 2018 

Aug 27 (Reuters) - MABION SA ::RECEIVES USD 5 MILLION MILESTONE PAYMENT FROM MYLAN IRELAND, FOLLOWING IMPLEMENTATION OF KEY STAGE IN COOPERATION AGREEMENT WITH MYLAN IRELAND.SAYS ACCORDING TO COOPERATION AGREEMENT IT IS ENTITLED TO GET UP TO ADDITIONAL USD 30 MILLION.FUTURE PAYMENTS DEPEND ON APPROVAL AND PROGRESS IN COMERCIALISATION OF MABIONCD20 DRUG.  Full Article

Mabion Receives Summary Of US FDA After Biological Development Meeting
Thursday, 28 Jun 2018 

June 28 (Reuters) - Mabion SA ::RECEIVES SUMMARY OF US FOOD AND DRUG ADMINISTRATION (FDA) AFTER A TYPE B BIOLOGICAL DEVELOPMENT (BPD) MEETING.  Full Article

Mabion Q1 Net Loss Widens To 14.3 Million Zlotys
Wednesday, 30 May 2018 

May 30 (Reuters) - MABION SA ::Q1 NET LOSS 14.3 MILLION ZLOTYS VERSUS LOSS OF 12.9 MILLION ZLOTYS YEAR AGO.  Full Article

Mabion To Replace GetBack In mWIG40
Monday, 7 May 2018 

May 7 (Reuters) - WARSAW STOCK EXCHANGE (WSE)::GETBACK SA <<>> WILL BE REPLACED IN THE WARSAW STOCK EXCHANGE'S MWIG40 INDEX .MWIG40 BY MABION SA <<>> AFTER THE SESSION ON MAY 8, WSE SAID IN A STATEMENT ON MAY 4.MABION'S PLACE IN SWIG80 INDEX .SWIG80 WILL BE TAKEN BY KRUSZWICA <<>>.GETBACK APPLIED FOR ACCELERATED ARRANGEMENT PROCEEDINGS AS PART OF ITS RESTRUCTURING ON MAY 2 nL8N1SB10H.  Full Article

Mabion To Increase Share Capital Through Private Share Issue
Wednesday, 18 Apr 2018 

April 18 (Reuters) - MABION SA ::SHAREHOLDERS AGREE ON SHARE CAPITAL INCREASE THROUGH ISSUE OF 1.9 MILLION OF SERIES P SHARES.SERIES P SHARE TO BE ISSUED VIA PRIVATE SHARE ISSUE WITHOUT PREEMPTIVE RIGHTS.SERIES P SHARE ISSUE PRICE SET AT 91 ZLOTY PER SHARE.THE MANAGEMENT BOARD HAS ALSO BEEN AUTHORIZED TO SETTLE THE ALLOTMENT OF SHARES THROUGH LOAN SETTLEMENT WITH SHAREHOLDER, TWITI INVESTMENTS LTD .  Full Article

Mabion To Get 63.3 Mln Zloty Subsidy For R&D Centre Enlargement
Wednesday, 4 Apr 2018 

April 5 (Reuters) - MABION SA ::SAID ON WEDNESDAY THAT ITS PROJECT REGARDING ENLARGEMENT OF THE COMPANY'S R&D CENTRE HAS BEEN CHOSEN FOR FINANCING.THE PROJECT TO BE FINANCED IN THE AMOUNT OF 63.3 MILLION ZLOTYS, THE TOTAL COST OF PROJECT AT 172.9 MILLION ZLOTYS.  Full Article

Mabion Q3 Net Loss Narrows To 13.2 Million Zlotys
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - MABION SA ::SAID ON WEDNESDAY THAT ITS Q3 NET LOSS WAS 13.2 MILLION ZLOTYS VERSUS LOSS OF 14.4 MILLION ZLOTYS.  Full Article

BRIEF-Mabion Files Second Patent Application

* SAID ON FRIDAY IT FILED A SECOND PATENT APPLICATION FOR ITS INVENTION FROM AREA OF ​​APPLICATION OF MABIONCD20 IN TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS 'LOW AGGREGATE ANTI CD20 LIGAND FORMULATION'